ESCAPE Bio (Crossover Financing)
Funding Details
- Awarder
- Inbox
- Date Award
- September 14, 2020
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $73,000,000
Company Info
- Company Description
- ESCAPE Bio is a clinical-stage biopharmaceutical company that develops small molecule drugs intended to treat neurodegenerative diseases.
- Market
- Genetically defined neurodegenerative diseases
- Location
- South San Francisco, California, USA
- Coinvestors
- Avidity Partners, CAM Capital, Johnson & Johnson Innovation, New Leaf Venture Partners, Novartis Venture Funds, Novo Holdings, OrbiMed Advisors, Osage University Partners, Rock Springs Capital, Sphera Funds Management, Surveyor Capital, Wellington Management Company